Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The trouble with the expense of treating hepatitis C virus (HCV) infections is that very few patients are acutely “choking” on it, since the largest pool of HCV patients are asymptomatic. Progression to end-stage liver disease, liver transplantation, and hepatocellular carcinoma — the three most dreaded HCV consequences — may seem distant to the asymptomatic or even modestly symptomatic patient.

Hepatitis C Treatment: Just How Much is it Worth to Cure a Dreadful Disease?